Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?
Open Access
- 16 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Osteoporosis International
- Vol. 31 (9), 1629-1632
- https://doi.org/10.1007/s00198-020-05465-2
Abstract
Summary The COVID-19 pandemic is influencing methods of healthcare delivery. In this short review, we discuss the evidence for remote healthcare delivery in the context of osteoporosis. Introduction The COVID-19 pandemic has undoubtedly had, and will continue to have, a significant impact on the lives of people living with, and at risk of, osteoporosis and those caring for them. With osteoporosis outpatient and Fracture Liaison Services on pause, healthcare organisations have already moved to delivering new and follow-up consultations remotely, where staffing permits, by telephone or video. Methods In this review, we consider different models of remote care delivery, the evidence for their use, and the possible implications of COVID-19 on osteoporosis services. Results Telemedicine is a global term used to describe any use of telecommunication systems to deliver healthcare from a distance and encompasses a range of different scenarios from remote clinical data transfer to remote clinician-patient interactions. Across a range of conditions and contexts, there remains unclear evidence on the acceptability of telemedicine and the effect on healthcare costs. Within the context of osteoporosis management, there is some limited evidence to suggest telemedicine approaches are acceptable to patients but unclear evidence on whether telemedicine approaches support informed drug adherence. Gaps in the evidence pertain to the acceptability and benefits of using telemedicine in populations with hearing, cognitive, or visual impairments and in those with limited health literacy. Conclusion There is an urgent need for further health service evaluation and research to address the impact of remote healthcare delivery during COVID-19 outbreak on patient care, and in the longer term, to identify acceptability and cost- and clinical-effectiveness of remote care delivery on outcomes of relevance to people living with osteoporosis.Keywords
Funding Information
- National Institute for Health Research (CS-2018-18-ST2-010)
This publication has 30 references indexed in Scilit:
- Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trialOsteoporosis International, 2011
- Effects of Home Telemonitoring to Support Improved Care for Chronic Obstructive Pulmonary DiseasesTelemedicine and e-Health, 2011
- Home telemonitoring of non-invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Medical Identity Theft and Telemedicine SecurityTelemedicine and e-Health, 2009
- Patient Satisfaction with Physician–Patient Communication During TelemedicineTelemedicine and e-Health, 2009
- A comparison of in-person home care, home care with telephone contact and home care with telemonitoring for disease managementJournal of Telemedicine and Telecare, 2009
- Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failureInternational Journal of Cardiology, 2009
- Impact of Telemedical Care and Monitoring on Morbidity in Mild to Moderate Chronic Heart FailureCardiology, 2008
- Comparison of Finger Tracking Versus Simple Movement Training via Telerehabilitation to Alter Hand Function and Cortical Reorganization After StrokeNeurorehabilitation and Neural Repair, 2007
- Education and Phone Follow-Up in Postmenopausal Women at Risk for OsteoporosisDisease Management and Health Outcomes, 2005